TME profiling revealed that the preferential superiority of the combination treatment regimens in the B16 melanoma model was associated with improved levels of tumor infiltration by mature DC, M1 macrophages, and activated CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.